Skip to main content

Table 2 Intergroup comparison of baseline and final best-corrected visual acuity and nasal, subfoveal, and temporal macular and choroidal thickness

From: Treatment results of diabetic macular edema with different choroidal thickness with intravitreal anti vascular endothelial growth factor

 

GROUP 1

GROUP 2

GROUP 3

 

Mean ± s.d /n-%

Med

Mean ± s.d /n-%

Med

Mean ± s.d /n-%

Med

Best Corrected Visual Acuity

 Baseline

0.64

 ± 

0.51

0.50

0.37

 ± 

0.37

0.30

0.47

 ± 

0.37

0.40

0.056

K

 Final

0.34

 ± 

0.23

0.30

0.43

 ± 

0.36

0.30

0.40

 ± 

0.38

0.30

0.748

K

 Baseline/Final Difference

-0.30

 ± 

0.44

-0.08

0.06

 ± 

0.33

0.00

-0.08

 ± 

0.33

0.00

0.008

K

Intra Group p Value

0.001

W

0.320

W

0.104

W

  

Nasal Choroidal Thickness

 Baseline

174.5

 ± 

30.1

178.0

234.2

 ± 

29.5

235.0

274.8

 ± 

32.7

271.0

0.000

A

 Final

179.3

 ± 

43.7

178.0

221.0

 ± 

27.2

225.0

261.3

 ± 

32.2

259.0

0.000

A

 Baseline/Final Difference

4.8

 ± 

31.1

6.0

-13.1

 ± 

30.9

-12.0

-13.5

 ± 

43.2

-15.0

0.063

A

 Intra Group p Value

0.367

P

0.036

P

0.042

P

  

Subfoveal Choroidal Thickness

 Baseline

190.2

 ± 

30.4

198.0

247.2

 ± 

14.2

249.0

296.2

 ± 

25.1

291.0

0.000

A

 Final

192.0

 ± 

39.6

195.0

230.7

 ± 

42.0

238.0

281.8

 ± 

33.3

283.0

0.000

A

 Baseline/Final Difference

1.8

 ± 

28.5

0.0

-16.5

 ± 

40.8

-14.0

-14.4

 ± 

34.7

-17.0

0.070

A

 Intra Group p Value

0.707

P

0.046

P

0.028

P

  

Temporal Choroidal Thickness

 Baseline

180.8

 ± 

29.1

180.0

230.1

 ± 

30.7

234.0

270.0

 ± 

28.0

265.0

0.000

A

 Final

184.1

 ± 

40.0

196.0

220.2

 ± 

29.4

215.0

259.0

 ± 

34.7

255.0

0.000

A

 Baseline/Final Difference

3.3

 ± 

30.3

-1.0

-9.9

 ± 

35.1

-13.0

-11.0

 ± 

34.5

-15.0

0.156

A

 Intra Group p Value

0.522

P

0.156

P

0.086

P

  

Nasal Macular Thickness

 Baseline

391.3

 ± 

79.3

351.0

376.9

 ± 

59.9

371.0

383.3

 ± 

59.3

369.0

0.875

K

 Final

340.9

 ± 

48.3

334.0

359.0

 ± 

70.5

343.0

380.9

 ± 

64.4

356.0

0.051

K

 Baseline/Final Difference

-50.5

 ± 

75.0

-39.0

-17.9

 ± 

57.8

-13.0

-2.4

 ± 

69.7

-2.0

0.052

K

 Intra Group p Value

0.001

W

0.049

W

0.814

W

  

Central Macular Thickness

 Baseline

359.4

 ± 

135.4

310.0

317.7

 ± 

71.2

304.0

349.6

 ± 

128.9

311.0

0.808

K

 Final

279.9

 ± 

78.0

265.0

294.6

 ± 

83.9

275.0

343.0

 ± 

117.6

309.0

0.052

K

 Baseline/Final Difference

-79.5

 ± 

144.5

-42.0

-23.1

 ± 

57.8

-14.0

-6.7

 ± 

122.8

-4.0

0.130

K

 Intra Group p Value

0.003

W

0.059

W

0.590

W

  

Temporal Macular Thickness

 Baseline

377.8

 ± 

82.1

346.0

344.4

 ± 

38.6

352.0

363.7

 ± 

57.4

348.0

0.674

K

 Final

334.4

 ± 

58.8

326.0

334.8

 ± 

47.2

328.0

383.8

 ± 

68.6

369.0

0.002

K

 Baseline/Final Difference

-43.5

 ± 

78.7

-24.0

-9.6

 ± 

47.0

-4.0

20.1

 ± 

69.0

6.0

0.002

K

 Intra Group p Value

0.000

W

0.000

W

0.000

W

  
  1. AANOVA / KKruskal–wallis (Mann–whitney u test) / wWilcoxon test / PPaired Samples t test